| 0 |
VARICOSE VEIN OPERATION |
1 |
0.0050 |
| 1 |
NASAL NEOPLASM |
1 |
0.0037 |
| 2 |
VIRAL MYOCARDITIS |
1 |
0.0027 |
| 3 |
GALLBLADDER PAIN |
1 |
0.0015 |
| 4 |
LEIOMYOMA |
1 |
0.0014 |
| 5 |
INJECTION SITE ULCER |
1 |
0.0011 |
| 6 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 7 |
NO ADVERSE EFFECT |
1 |
0.0006 |
| 8 |
CONCOMITANT DISEASE PROGRESSION |
1 |
0.0005 |
| 9 |
INJECTION SITE NECROSIS |
1 |
0.0005 |
| 10 |
UTERINE HAEMORRHAGE |
2 |
0.0005 |
| 11 |
FACIAL PALSY |
1 |
0.0005 |
| 12 |
APHTHOUS STOMATITIS |
1 |
0.0004 |
| 13 |
LABYRINTHITIS |
1 |
0.0004 |
| 14 |
TUBERCULIN TEST POSITIVE |
1 |
0.0004 |
| 15 |
HYPERTONIC BLADDER |
1 |
0.0003 |
| 16 |
VENTRICULAR HYPOKINESIA |
1 |
0.0003 |
| 17 |
PEPTIC ULCER |
1 |
0.0003 |
| 18 |
WOUND COMPLICATION |
1 |
0.0003 |
| 19 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 20 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 21 |
INJECTION SITE INFLAMMATION |
1 |
0.0002 |
| 22 |
VARICOSE VEIN |
1 |
0.0002 |
| 23 |
INTRA-UTERINE CONTRACEPTIVE DEVICE EXPELLED |
1 |
0.0002 |
| 24 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 25 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 26 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 27 |
APPENDICITIS |
1 |
0.0001 |
| 28 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 29 |
GASTRIC ULCER |
2 |
0.0001 |
| 30 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 31 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 32 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 33 |
MYOCARDITIS |
1 |
0.0001 |
| 34 |
NEOPLASM |
1 |
0.0001 |
| 35 |
BURSITIS |
1 |
0.0001 |
| 36 |
TENDON RUPTURE |
1 |
0.0001 |
| 37 |
PHARYNGITIS |
1 |
0.0001 |
| 38 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 39 |
POISONING |
1 |
0.0001 |
| 40 |
HIATUS HERNIA |
1 |
0.0001 |
| 41 |
TOOTH INFECTION |
1 |
0.0001 |
| 42 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 43 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 44 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 45 |
COLD SWEAT |
1 |
0.0001 |
| 46 |
THIRST |
1 |
0.0001 |
| 47 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 48 |
EYE SWELLING |
2 |
0.0001 |
| 49 |
CHOKING |
1 |
0.0001 |
| 50 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 51 |
RETCHING |
1 |
0.0000 |
| 52 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 53 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 54 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 55 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 56 |
HEPATITIS |
1 |
0.0000 |
| 57 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 58 |
HAEMATOMA |
1 |
0.0000 |
| 59 |
DIPLOPIA |
1 |
0.0000 |
| 60 |
GASTRITIS |
1 |
0.0000 |
| 61 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 62 |
OEDEMA |
2 |
0.0000 |
| 63 |
SKIN LESION |
1 |
0.0000 |
| 64 |
TACHYCARDIA |
3 |
0.0000 |
| 65 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 66 |
INJECTION SITE RASH |
1 |
0.0000 |
| 67 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 68 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 69 |
CHOLELITHIASIS |
1 |
0.0000 |
| 70 |
URINARY RETENTION |
1 |
0.0000 |
| 71 |
RASH MACULAR |
1 |
0.0000 |
| 72 |
BURNING SENSATION |
2 |
0.0000 |
| 73 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 74 |
DYSURIA |
1 |
0.0000 |
| 75 |
INJECTION SITE MASS |
1 |
0.0000 |
| 76 |
DYSGEUSIA |
2 |
0.0000 |
| 77 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 78 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 79 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 80 |
TINNITUS |
1 |
0.0000 |
| 81 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 82 |
ARRHYTHMIA |
1 |
0.0000 |
| 83 |
LUNG DISORDER |
1 |
0.0000 |
| 84 |
HEART RATE INCREASED |
2 |
0.0000 |
| 85 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 86 |
INFLAMMATION |
1 |
0.0000 |
| 87 |
NECK PAIN |
1 |
0.0000 |
| 88 |
BONE PAIN |
1 |
0.0000 |
| 89 |
FEELING HOT |
1 |
0.0000 |
| 90 |
CHEST PAIN |
3 |
0.0000 |
| 91 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 92 |
AMNESIA |
1 |
0.0000 |
| 93 |
HYPERTENSION |
3 |
0.0000 |
| 94 |
HYPOAESTHESIA |
2 |
0.0000 |
| 95 |
DEPRESSION |
3 |
0.0000 |
| 96 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 97 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 98 |
CARDIAC ARREST |
1 |
0.0000 |
| 99 |
TREMOR |
2 |
0.0000 |
| 100 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 101 |
BALANCE DISORDER |
1 |
0.0000 |
| 102 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 103 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 104 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 105 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 106 |
CARDIAC DISORDER |
1 |
0.0000 |
| 107 |
ALOPECIA |
2 |
0.0000 |
| 108 |
CONSTIPATION |
2 |
0.0000 |
| 109 |
BACK PAIN |
2 |
0.0000 |
| 110 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 111 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 112 |
HYPERHIDROSIS |
1 |
0.0000 |
| 113 |
INSOMNIA |
2 |
0.0000 |
| 114 |
DEHYDRATION |
1 |
0.0000 |
| 115 |
HEADACHE |
4 |
0.0000 |
| 116 |
DRUG INTERACTION |
1 |
0.0000 |
| 117 |
URTICARIA |
1 |
0.0000 |
| 118 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 119 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 120 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 121 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 122 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 123 |
HYPOTENSION |
1 |
0.0000 |
| 124 |
SOMNOLENCE |
1 |
0.0000 |
| 125 |
ARTHRALGIA |
2 |
0.0000 |
| 126 |
DIARRHOEA |
3 |
0.0000 |
| 127 |
WEIGHT INCREASED |
1 |
0.0000 |
| 128 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 129 |
VOMITING |
2 |
0.0000 |
| 130 |
FEELING ABNORMAL |
1 |
0.0000 |
| 131 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 132 |
FATIGUE |
3 |
0.0000 |
| 133 |
WEIGHT DECREASED |
1 |
0.0000 |
| 134 |
DYSPNOEA |
2 |
0.0000 |
| 135 |
ANXIETY |
1 |
0.0000 |
| 136 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 137 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 138 |
PAIN |
2 |
0.0000 |
| 139 |
FALL |
1 |
0.0000 |
| 140 |
PYREXIA |
1 |
0.0000 |
| 141 |
PRURITUS |
1 |
0.0000 |
| 142 |
NAUSEA |
2 |
0.0000 |
| 143 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 144 |
DIZZINESS |
1 |
0.0000 |
| 145 |
DEATH |
1 |
0.0000 |
| 146 |
OFF LABEL USE |
1 |
0.0000 |